Sentinel Lymph Node Sln
Mostrando 1-12 de 13 artigos, teses e dissertações.
-
1. Accuracy of sentinel lymph node mapping in detecting occult neck metastasis in papillary thyroid carcinoma
ABSTRACT Objectives: The objectives of this study were to evaluate the following: 1) the accuracy of sentinel lymph node mapping (SLNM) in detecting metastasis in papillary thyroid carcinoma (PTC), and 2) if SLNM could modify the American Joint Committee on Cancer (AJCC) staging of previous cN0 PTC patients. Subjects and methods: Forty SLNM were performed
Arch. Endocrinol. Metab.. Publicado em: 17/05/2018
-
2. Comparison between hemosiderin and Technetium-99 in sentinel lymph node biopsy in human breast cancer
PURPOSE: To assess the safety and potential equivalence of the use of hemosiderin compared to the Technetium-99 in sentinel lymph node biopsy in human breast cancer. METHODS: Non-random sample of 14 volunteer women diagnosed with breast cancer with primary tumors (T1/T2) and clinically tumor-free axilla were submitted to the identification of sentinel lymp
Acta Cir. Bras.. Publicado em: 2015-11
-
3. Modelo experimental para pesquisa de linfonodo sentinela no penis do cÃo / Identification of sentinel lymph of inguinal region in dogs Model
Cancer of the penis is a rare neoplasm in developed countries, but troubling in the countries of Latin America, Asia and Africa. In Brazil represents about 2% of male malignancies. Considering this incidence is estimated for 2010 some 160 new cases in CearÃ. Because there is a scarcity of publications on this disease, there are still numerous issues in thei
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 17/12/2010
-
4. Sentinel node biopsy in breast cancer: results in a large series
Sentinel lymph node biopsy (SLNB) is an appropriate method for the evaluation of axillary status in cases of early breast cancer. We report our experience in treating cases evaluated using SLNB. We analyzed a total of 1192 cases assessed by means of SLNB from July 1999 to December 2007. SLNB processing was successfully completed in 1154 cases with the use of
Brazilian Journal of Medical and Biological Research. Publicado em: 2010-06
-
5. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer
Our objective was to determine the presence of vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2) and MMP-9 and specific tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) in tumor samples obtained from patients with primary breast cancer. We attempted to correlate these findings with the status of the sentinel lymph
Brazilian Journal of Medical and Biological Research. Publicado em: 04/09/2009
-
6. Localização histologica das metastases nos linfonodos sentinelas e fatores de risco para predizer positividade dos linfonodos não-sentinelas em cancer de mama / Histologic localization of sentinel lymph nodes metastases and risk factors for prediction of non-sentinel lymph nodes positivity in breast cancer
INTRODUCTION: The complete axillary lymph node dissection is the standard treatment for patients with positive sentinel lymph node (SLN) in breast cancer. However, several studies report that 38 to 67% of patients with positive SLN do not have involvement of the non-sentinel lymph nodes (NSLN). OBJECTIVE: The purpose of this study is to explore the orphologi
Publicado em: 2007
-
7. Identificação do linfonodo-sentinela em pacientes com carcinoma de colo uterino invasor estádio I-B 1
Objetivo: determinar a viabilidade da identificação do linfonodo-sentinela em pacientes com câncer invasor de colo uterino estádio Ib1. Material e Métodos: 16 pacientes consecutivas com câncer de colo uterino agendadas para histerectomia radical com linfadenectomia pélvica bilateral realizaram estudo para detecção de linfonodo-sentinela. Onze pacien
Publicado em: 2007
-
8. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up.
AIM: To assess the value of the intensive histological work up of axillary sentinel lymph nodes (SLN) to demonstrate regional metastatic disease. METHODS: From a series of 58 successful lymphatic mapping procedures, 78 SLN were analysed by serial sections (mean of 49 levels/SLN) and by immunostaining to cytokeratin and epithelial membrane antigen, and the re
-
9. Clinical aspects of sentinel node biopsy
Sentinel lymph node (SLN) biopsy requires validation by a backup axillary dissection in a defined series of cases before becoming standard practice, to establish individual and institutional success rates and the frequency of false negative results. At least 90% success in finding the SLN with no more than 5-10% false negative results is a reasonable goal fo
BioMed Central.
-
10. High-speed dynamic 3D photoacoustic imaging of sentinel lymph node in a murine model using an ultrasound array
Noninvasive photoacoustic sentinel lymph node (SLN) mapping with high spatial resolution has the potential to improve the false negative rate and eliminate the use of radioactive tracers in SLN identification. In addition, the demonstrated high spatial resolution may enable physicians to replace SLN biopsy with fine needle aspiration biopsy, and thus reduce
American Association of Physicists in Medicine.
-
11. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
OBJECTIVE: To define preliminary guidelines for the use of lymphatic mapping techniques in patients with breast cancer. SUMMARY BACKGROUND DATA: Lymphatic mapping techniques have the potential of changing the standard of surgical care of patients with breast cancer. METHODS: Four hundred sixty-six consecutive patients with newly diagnosed breast cancer under
-
12. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.
BACKGROUND: The sentinel lymph node (SLN), the first node draining the primary tumor site, has been shown to reflect the histologic features of the remainder of the lymphatic basin in patients with melanoma. Intraoperative localization of the SLN, first proposed by Morton and colleagues, has been accomplished with the use of a vital blue dye mapping techniqu